Study of ATI-1013 in healthy smokers who want to quit
Treatments studied
Part of Heart & circulation, Mental health clinical trials.
This trial tests a new drug called ATI-1013 in healthy smokers. It aims to see how safe the drug is and how it works in the body. If you smoke at least 10 cigarettes a day and are in good health, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 23 and 59 years old.
- You must be a current smoker of at least 10 cigarettes a day for 2 years or more.
- You must be in good general health with no serious medical conditions.
- You must not have used any other smoking cessation treatments in the last 90 days.
- Women must not be pregnant or planning pregnancy and must use birth control during the study.
- You must avoid all tobacco and nicotine products for certain periods during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This first-in-human study tests the safety of a new medicine called VNT-101. Healthy adults aged 18 to 59 who do not smoke and have no major health problems may be able to join. The goal is to see how the body handles the drug and if it is safe.
This study tests how much people might want to use five different types of modern oral nicotine products (like pouches or lozenges) compared to smoking their usual cigarette. It helps researchers understand if these products could be less addictive than cigarettes.
This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.
This study tests how people may misuse or become dependent on heated tobacco products (a type of electronic device that heats tobacco instead of burning it). If you qualify, you'll spend 10 days in a clinic and try these products to help researchers understand their effects.
This trial tests an injectable drug called brenipatide to see if it helps people who have recently quit smoking stay quit for good. The study follows participants over time and requires them to come to clinic visits.
This trial tests how different electronic nicotine products (e-cigarettes) affect your feelings and cravings compared to your usual cigarettes. You'll stay at a clinic for 10 days and try different products to see if they reduce your urge to smoke.
Hear when a new Thromboangiitis Obliterans (Buerger's Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.